Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Getting the Gist Across Is Enough for Informed Consent for Acute Stroke Thrombolytics.

Literature DB >> 31084320

Getting the Gist Across Is Enough for Informed Consent for Acute Stroke Thrombolytics.

Lesli E Skolarus^1,2, Alison O'Brien^1,2, William J Meurer^1,3, Brian J Zikmund Fisher².

Abstract

Entities: Disease Gene Species

Keywords: decision-making; emergency medicine; informed consent; neurology; risk; tissue-type plasminogen activator

Mesh：

Substances：
Fibrinolytic Agents

Year: 2019 PMID： 31084320 PMCID： PMC6538464 DOI： 10.1161/STROKEAHA.119.024653

Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914

× No keyword cloud information.

24 in total

1. Less is more in presenting quality information to consumers.

Authors: Ellen Peters; Nathan Dieckmann; Anna Dixon; Judith H Hibbard; C K Mertz
Journal: Med Care Res Rev Date: 2007-04 Impact factor: 3.929

2. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal: Lancet Date: 2007-01-27 Impact factor: 79.321

3. Patient-Centered Decision Support in Acute Ischemic Stroke: Qualitative Study of Patients' and Providers' Perspectives.

Authors: Carole Decker; Emily Chhatriwalla; Elizabeth Gialde; Brian Garavalia; Debbie Summers; Miriam E Quinlan; Eric Cheng; Marilyn Rymer; Jeffrey L Saver; Er Chen; David M Kent; John A Spertus
Journal: Circ Cardiovasc Qual Outcomes Date: 2015-10

Review 4. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors: William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal: Stroke Date: 2018-01-24 Impact factor: 7.914

5. Racial disparities in refusal of stroke thrombolysis in Chicago.

Authors: Scott J Mendelson; Neelum T Aggarwal; Christopher Richards; Kathleen O'Neill; Jane L Holl; Shyam Prabhakaran
Journal: Neurology Date: 2018-01-03 Impact factor: 9.910

6. Tissue plasminogen activator for acute ischemic stroke.

Authors:
Journal: N Engl J Med Date: 1995-12-14 Impact factor: 91.245

Review 7. Intravenous Recombinant Tissue Plasminogen Activator and Ischemic Stroke: Focused Update of 2010 Clinical Practice Advisory From the American Academy of Emergency Medicine.

Authors: William J Meurer; Bradley Barth; Michael Abraham; Jerome R Hoffman; Gary M Vilke; Gerard DeMers
Journal: J Emerg Med Date: 2018-03-12 Impact factor: 1.484

8. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm.

Authors: Jeffrey L Saver
Journal: Stroke Date: 2007-07-19 Impact factor: 7.914

9. Professional guideline versus product label selection for treatment with IV thrombolysis: An analysis from SITS registry.

Authors: Alan C Cameron; James Bogie; Azmil H Abdul-Rahim; Niaz Ahmed; Michael Mazya; Robert Mikulik; Werner Hacke; Kennedy R Lees
Journal: Eur Stroke J Date: 2017-12-08

4. Effect of Optimized Emergency Care on Treatment Rate and Prognosis of Elderly Patients with Acute Stroke in Emergency Department: A Systematic Review and Meta-Analysis.

Authors: Xia Liang; Yanhong Yu
Journal: Comput Math Methods Med Date: 2022-07-26 Impact factor: 2.809

4 in total